Propofol MCT Fresenius 10 mg/ml

Propofol MCT Fresenius 10 mg/ml is a medicine authorised by Swissmedic under authorisation number 57029. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 November 2005 and the authorisation is valid without a time limit. ATC code N01AX10 places the medicine in the group Anesthetics.

  • Dispensing category B
  • Authorisation number 57029
  • ATC N01AX10
  • Synthetic medicines
Authorisation data
Authorisation number57029
NamePropofol MCT Fresenius 10 mg/ml
Full namePropofol MCT Fresenius 10 mg/ml, Emulsion zur Injektion/Infusion
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN01AX10
First authorisation04 November 2005
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Propofol MCT Fresenius 10 mg/ml, Emulsion zur Injektion/InfusionB04 November 2005
2Propofol MCT Fresenius 20 mg/ml, Emulsion zur InfusionB04 November 2005

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110 x 20mlN01AX1001.02.1.B
25 x 20mlN01AX1001.02.1.B
145 x 20mlN01AX1001.02.1.B
1510 x 50mlN01AX1001.02.1.B
1610 x 100mlN01AX1001.02.1.B
85 x 20mlN01AX1001.02.1.B
1710 x 50mlN01AX1001.02.1.B
1810 x 100mlN01AX1001.02.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Propofol MCT Fresenius 10 mg/ml authorised in Switzerland?

Yes. Propofol MCT Fresenius 10 mg/ml is authorised by Swissmedic under authorisation number 57029, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Propofol MCT Fresenius 10 mg/ml have?

Propofol MCT Fresenius 10 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Propofol MCT Fresenius 10 mg/ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com